HRP20050760A2 - Method of obtaining cell lines in a protein-free medium and cell lines thus obtained - Google Patents

Method of obtaining cell lines in a protein-free medium and cell lines thus obtained

Info

Publication number
HRP20050760A2
HRP20050760A2 HR20050760A HRP20050760A HRP20050760A2 HR P20050760 A2 HRP20050760 A2 HR P20050760A2 HR 20050760 A HR20050760 A HR 20050760A HR P20050760 A HRP20050760 A HR P20050760A HR P20050760 A2 HRP20050760 A2 HR P20050760A2
Authority
HR
Croatia
Prior art keywords
cell lines
protein
free medium
serum
concentrations
Prior art date
Application number
HR20050760A
Other languages
English (en)
Croatian (hr)
Inventor
Perez Rodriguez Rolando
Castillo Vitlloch Adolfo
Vitores Sarazola Svieta
Boggiano Ayo Tammy
Rojas Del Calvo Luis
Original Assignee
Centro De Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Inmunologia Molecular filed Critical Centro De Inmunologia Molecular
Publication of HRP20050760A2 publication Critical patent/HRP20050760A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HR20050760A 2002-10-23 2003-10-22 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained HRP20050760A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20020239A CU23097A1 (es) 2002-10-23 2002-10-23 Método para la obtención de líneas celulares en medio libre de proteína y líneas celulares obtenidas por este método
PCT/CU2003/000012 WO2004038010A1 (es) 2002-10-23 2003-10-22 Método para la obtención de líneas celulares en medio libre de proteína y líneas celulares obtenidas por este método

Publications (1)

Publication Number Publication Date
HRP20050760A2 true HRP20050760A2 (en) 2006-08-31

Family

ID=40134843

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050760A HRP20050760A2 (en) 2002-10-23 2003-10-22 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained

Country Status (27)

Country Link
US (2) US20060036082A1 (pt)
EP (2) EP1564285B1 (pt)
JP (1) JP4674087B2 (pt)
KR (1) KR101186048B1 (pt)
CN (1) CN1714147B (pt)
AR (1) AR041645A1 (pt)
AT (1) ATE502103T1 (pt)
AU (1) AU2003273727B2 (pt)
BR (1) BR0315565B1 (pt)
CA (1) CA2503315C (pt)
CU (1) CU23097A1 (pt)
DE (1) DE60336415D1 (pt)
DK (1) DK1564285T3 (pt)
EA (1) EA007465B1 (pt)
EC (1) ECSP055740A (pt)
ES (2) ES2360049T3 (pt)
GE (1) GEP20084444B (pt)
HR (1) HRP20050760A2 (pt)
LT (1) LT5354B (pt)
LV (1) LV13361B (pt)
MY (1) MY144088A (pt)
NZ (1) NZ540171A (pt)
PE (1) PE20040552A1 (pt)
PT (1) PT1564285E (pt)
TN (1) TNSN05116A1 (pt)
UY (1) UY28037A1 (pt)
WO (1) WO2004038010A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104651314B (zh) * 2015-02-14 2018-06-19 百泰生物药业有限公司 获得高产稳定表达细胞克隆的方法及由此获得的抗体分子
CN104673754B (zh) * 2015-02-14 2018-03-02 百泰生物药业有限公司 重组骨髓瘤细胞克隆的筛选方法及由此获得的抗体分子

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3694263A (en) * 1970-10-23 1972-09-26 Joseph J Korn Sr Swimming pool cleaning methods and apparatus therefor
CU22545A1 (es) 1994-11-18 1999-03-31 Centro Inmunologia Molecular Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
US3886616A (en) * 1972-12-06 1975-06-03 Fay A Hayes Hand propelled swimming pool cleaner
US4275474A (en) * 1979-04-30 1981-06-30 Woodard Randle C Vacuum head for swimming pool cleaning system
US4240174A (en) * 1979-07-30 1980-12-23 Scott Jeffrey L Self-contained mobile pool cleaning apparatus
US4430214A (en) * 1982-09-15 1984-02-07 Baker Marvin E Strainer mill for swimming pool pump intake
AU2986484A (en) * 1983-06-27 1985-01-03 Monash University Leptospira strains grown in protein free medium
US4558479A (en) * 1984-01-26 1985-12-17 Alopex Industries, Inc. Pool cleaner
US4683599A (en) * 1984-03-30 1987-08-04 Fahet Nv Automatic pool cleaner fitting
US4581075A (en) * 1985-03-15 1986-04-08 Maxi-Sweep, Inc. Self-propelled water borne pool cleaner
JP2895622B2 (ja) 1989-09-29 1999-05-24 アトミック エナジィ オブ カナダ リミテッド 赤外線を用いたガス検出器
JP2696001B2 (ja) 1991-04-15 1998-01-14 財団法人化学及血清療法研究所 組換え蛋白質産生用培地
EP0531562A1 (de) 1991-09-11 1993-03-17 Doerr, Hans-Wilhelm, Prof. Dr. med. Kultivierung von Säugetierzellen
ATE370235T1 (de) * 1994-09-16 2007-09-15 Cancer Res Fund Of Contra Cost Rekombinantpeptide hergeleitet vom mc3 antikörper gegen ba46, verfahren zu deren verwendung und verfahren zur humanisierung von antikörperpeptiden
ATE542891T1 (de) 1994-11-10 2012-02-15 Baxter Healthcare Sa Verfahren zur herstellung von biologischen produkten in protein-freier kultur
WO1996026266A1 (en) 1995-02-23 1996-08-29 Quest International B.V. Peptides for tissue and cell culture media
AUPN442295A0 (en) 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
CU22584A1 (es) 1995-11-17 1999-11-03 Centro Inmunologia Molecular Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis
AT407255B (de) * 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons

Also Published As

Publication number Publication date
EP1564285A1 (en) 2005-08-17
EA200500695A1 (ru) 2005-10-27
CA2503315C (en) 2014-02-18
LV13361B (en) 2006-02-20
AR041645A1 (es) 2005-05-26
KR101186048B1 (ko) 2012-09-25
JP4674087B2 (ja) 2011-04-20
US20060036082A1 (en) 2006-02-16
KR20050088403A (ko) 2005-09-06
WO2004038010A1 (es) 2004-05-06
ES2624279T3 (es) 2017-07-13
CN1714147A (zh) 2005-12-28
BR0315565A (pt) 2005-08-23
HK1084414A1 (en) 2006-07-28
EA007465B1 (ru) 2006-10-27
CU23097A1 (es) 2005-11-18
LT5354B (lt) 2006-07-25
AU2003273727B2 (en) 2008-04-03
PE20040552A1 (es) 2004-10-26
ES2360049T3 (es) 2011-05-31
BR0315565B1 (pt) 2022-01-25
US20100197011A1 (en) 2010-08-05
UY28037A1 (es) 2004-04-30
EP2363418A2 (en) 2011-09-07
CN1714147B (zh) 2011-01-12
NZ540171A (en) 2008-04-30
CA2503315A1 (en) 2004-05-06
TNSN05116A1 (en) 2007-05-14
JP2006503879A (ja) 2006-02-02
EP2363418B1 (en) 2017-02-08
DK1564285T3 (da) 2011-05-16
GEP20084444B (en) 2008-08-10
AU2003273727A1 (en) 2004-05-13
PT1564285E (pt) 2011-04-20
EP1564285B1 (en) 2011-03-16
EP2363418A3 (en) 2011-11-16
MY144088A (en) 2011-08-15
DE60336415D1 (de) 2011-04-28
LT2005053A (en) 2006-04-25
ATE502103T1 (de) 2011-04-15
ECSP055740A (es) 2005-09-20

Similar Documents

Publication Publication Date Title
Waymouth Rapid proliferation of sublines of NCTC clone 929 (strain L) mouse cells in a simple chemically defined medium (MB 752/1)
Murado et al. Optimization of extraction and purification process of hyaluronic acid from fish eyeball
BR9915026A (pt) Móleculas de ácido nucléico codificando uma enzima ramificadora de bactérias do gênero neisseria bem como métodos para a produção de alfa-1,4 glicanos ramificados para alfa-1,6
DE69217491D1 (de) Verfahren zur enzymatischen herstellung von alpha-sialylierten oligosaccharid-glykosiden
CY1110267T1 (el) Μεθοδος για την καλλιεργεια κυτταρων για την παραγωγη ουσιων
DE602004014158D1 (de) Verfahren zur herstellung von l-lysin oder l-threonin unter verwendung von escherichia-bakterien mit abgeschwächter malatenzymaktivität
ATE153214T1 (de) Medien zur zellzucht und verfahren dazu
ATE215135T1 (de) Verfahren zur herstellung von solvens- stabilisierten metallkolloiden und trägerfixierten metallclustern
ATE242816T1 (de) Verfahren zur reinigung von hyaluronsäure mit hohem molekulargewicht
de Luca et al. Variations in enzyme activities during the growth of mammalian cells in vitro: Lactate and glucose-6-phosphate dehydrogenases
DK1202983T3 (da) Fremgangsmåde til fremstilling af opløsningsmiddelfri alfa-liponsyre
FI964014A0 (fi) Menetelmä sähkökemiallisen kennon valmistamiseksi
RU2018130530A (ru) Способ получения активного фактора роста гепатоцитов (hgf)
BRPI0409801A (pt) método para produzir ácido l-glutámico por fermentação
DE50007153D1 (de) 3d-matrix zur herstellung von zelltransplantaten
ATE358681T1 (de) Verfahren zur rekombinanten herstellung von plazenta wachstumsfaktor
DK0870052T3 (da) Fremgangsmåde til fremstilling af gluconsyre og gluconsyre fremstillet derved
CN118948690A (zh) 一种具有调控皮肤细胞钙离子作用的欧洲赤松芽提取物及其制备方法与应用
DK0533849T3 (da) Sucrosephosphatsyntase (SPS), fremgangsmåde til dens fremstilling, dens cDNA og anvendelse af cDNA til at ændre ekspression
Soares-da-Silva et al. Uptake of L-3, 4-dihydroxyphenylalanine and dopamine formation in cultured renal epithelial cells
Phillips Effects of sequential exposure to auxin and cytokinin on xylogenesis in cultured explants of Jerusalem artichoke (Helianthus tuberosus L.)
JP2991620B2 (ja) 細胞活動の制御方法
GB1385871A (en) Production of streptokinase
DK0873372T3 (da) Fremgangsmåde til fremstilling af kationbyttermembraner imprægneret med uopløslige metalsalte
Sosnowska et al. Evaluation of a human placenta-derived hydrogel to support glucose sensitive insulin secretion in human donor islets

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20121022

Year of fee payment: 10

OBST Application withdrawn